Asplenia screening

Jump to navigation Jump to search

Asplenia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Asplenia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Asplenia screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Asplenia screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Asplenia screening

CDC on Asplenia screening

Asplenia screening in the news

Blogs on Asplenia screening

Directions to Hospitals Treating Asplenia

Risk calculators and risk factors for Asplenia screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalpana Giri, MBBS[2]

Overview

Screening for asplenia is by the detection of Howell-Jolly bodies (ie, erythrocytes with nuclear remnants) in peripheral blood smear.[1]

Screening

Screening for asplenia is by the detection of Howell-Jolly bodies (ie, erythrocytes with nuclear remnants) in peripheral blood smear.[1]

References

  1. 1.0 1.1 Corazza GR, Ginaldi L, Zoli G, Frisoni M, Lalli G, Gasbarrini G; et al. (1990). "Howell-Jolly body counting as a measure of splenic function. A reassessment". Clin Lab Haematol. 12 (3): 269–75. doi:10.1111/j.1365-2257.1990.tb00037.x. PMID 2125541.

Template:WS Template:WH